These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23244384)

  • 1. Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part II: Management of stage IV disease.
    Fox MC; Lao CD; Schwartz JL; Frohm ML; Bichakjian CK; Johnson TM
    J Am Acad Dermatol; 2013 Jan; 68(1):13.e1-13; quiz 26-8. PubMed ID: 23244384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part I: Management of stage III disease.
    Fox MC; Lao CD; Schwartz JL; Frohm ML; Bichakjian CK; Johnson TM
    J Am Acad Dermatol; 2013 Jan; 68(1):1.e1-9; quiz 10-12. PubMed ID: 23244383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Systemic treatment of melanoma brain metastases].
    Le Rhun É; Mateus C; Mortier L; Dhermain F; Guillot B; Grob JJ; Lebbe C; Thomas M; Jouary T; Leccia MT; Robert C
    Cancer Radiother; 2015 Feb; 19(1):48-54. PubMed ID: 25656856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic strategies and systemic treatment of brain melanoma metastases].
    Durando X; Mansard S; Daste A; Gimbergues P; Brocard L; Magné N; Thivat E
    Bull Cancer; 2013 Jan; 100(1):23-8. PubMed ID: 22889847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of patients with metastatic cutaneous melanoma: French national guidelines. French National Cancer Institute].
    Leccia MT; Planchamp F; Sassolas B; Combemale P; Modiano P; Bedane C; Cupissol D; Derrey S; Dygai-Cochet I; Lamant L; Lubrano V; Mirabel X; Mourrégot A; Rougé Bugat ME; Siegrist S; Thariat J; Tiffet O; Truc G; Verdoni L; Mazeau-Woynar V
    Ann Dermatol Venereol; 2014 Feb; 141(2):111-21. PubMed ID: 24507205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upcoming strategies for the treatment of metastatic melanoma.
    Spagnolo F; Queirolo P
    Arch Dermatol Res; 2012 Apr; 304(3):177-84. PubMed ID: 22350184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current systemic therapies for melanoma.
    Palathinkal DM; Sharma TR; Koon HB; Bordeaux JS
    Dermatol Surg; 2014 Sep; 40(9):948-63. PubMed ID: 25072125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the treatment of melanoma.
    Lacy KE; Karagiannis SN; Nestle FO
    Clin Med (Lond); 2012 Apr; 12(2):168-71. PubMed ID: 22586796
    [No Abstract]   [Full Text] [Related]  

  • 9. Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma.
    Gibney GT; Atkins MB
    J Clin Oncol; 2015 Jun; 33(17):1873-7. PubMed ID: 25964248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in the medical and surgical treatment of melanoma.
    Saranga-Perry V; Ambe C; Zager JS; Kudchadkar RR
    CA Cancer J Clin; 2014; 64(3):171-85. PubMed ID: 24676837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma brain metastasis: overview of current management and emerging targeted therapies.
    Fonkem E; Uhlmann EJ; Floyd SR; Mahadevan A; Kasper E; Eton O; Wong ET
    Expert Rev Neurother; 2012 Oct; 12(10):1207-15. PubMed ID: 23082737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecularly targeted therapies for melanoma.
    Liu LS; Colegio OR
    Int J Dermatol; 2013 May; 52(5):523-30. PubMed ID: 23590367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma.
    Dummer R; Siano M; Hunger RE; Lindenblatt N; Braun R; Michielin O; Mihic-Probst D; von Moos R; Najafi Y; Guckenberger M; Arnold A
    Swiss Med Wkly; 2016; 146():w14279. PubMed ID: 26901103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment with vemurafenib in BRAF V600K-positive cerebral melanoma metastasis.
    Forschner A; Niessner H; Bauer J; Bender B; Garbe C; Meier F
    JAMA Dermatol; 2013 May; 149(5):642-4. PubMed ID: 23677116
    [No Abstract]   [Full Text] [Related]  

  • 15. Asymptomatic brain metastases in patients with cutaneous metastatic malignant melanoma.
    Zukauskaite R; Schmidt H; Asmussen JT; Hansen O; Bastholt L
    Melanoma Res; 2013 Feb; 23(1):21-6. PubMed ID: 23117880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for brain metastases from melanoma.
    McWilliams RR; Rao RD; Brown PD; Link MJ; Buckner JC
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):809-20. PubMed ID: 16221051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients.
    Schaefer T; Satzger I; Gutzmer R
    Medicine (Baltimore); 2017 Jan; 96(1):e5753. PubMed ID: 28072717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo.
    Fukumoto T; Fujiwara S; Sakaguchi M; Oka M; Kiyota N; Ejima Y; Nakajima K; Nishigori C
    Eur J Dermatol; 2017 Apr; 27(2):177-178. PubMed ID: 27873735
    [No Abstract]   [Full Text] [Related]  

  • 19. Vemurafenib for melanoma metastases to the brain.
    Rochet NM; Kottschade LA; Markovic SN
    N Engl J Med; 2011 Dec; 365(25):2439-41. PubMed ID: 22188003
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
    Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M
    Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.